Insight Molecular Diagnostics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $3.4M | $8.0M |
| FY2019 | — | $30.8M | $22.1M |
| FY2020 | — | $33.5M | $7.1M |
| FY2021 | — | $65.2M | $32.9M |
| FY2022 | — | $34.3M | $20.0M |
| FY2023 | — | $20.5M | $9.4M |
| FY2024 | — | $-12.3M | $8.6M |
| FY2025 | — | $-31.5M | $11.6M |